Orthodontic Photobiomodulation Group Launches OrthoPulse in the United States

Orthodontic technology company, Biolux Technology has announced the U.S. launch of its updated OrthoPulse product and platform. This new version, OrthoPulse 2.0, reportedly offers enhanced reliability and an expanded pool of clinical evidence to bolster orthodontic care, according to a press release from BioLux Technology.

"OrthoPulse and its platform have become a standard of care, especially for complex adult aligner treatments. We have successfully treated hundreds of patients with OrthoPulse, resulting in significantly reduced refinements. We highly recommend utilizing this innovative technology," said Dr Leone Paola in the press release.

Micheal Hendricks will lead this new phase for OrthoPulse in the U.S., which, according to BioLux, is a commitment to advancing the company’s mission. He expressed enthusiasm in the press release. "Our improved product, combined with robust clinical evidence, positions us to better serve our partner doctors and advance the field of orthodontics. We look forward to establishing our presence and building strong relationships with our clinicians."

OrthoPulse's technology uses photobiomodulation to stimulate the bone surrounding the roots of teeth which enables tooth movement for aligner and bracket patients. Photobiomodulation is a non-invasive treatment option, which may make it appealing to patients who are seeking efficient and comfortable orthodontic care, per the press release.

To learn more about Orthopulse, visit the website here.